News
Organic sales rose 1.4% during the quarter, with pricing up 1.5% and volume down 0.1%. The impact of FX was a negative 4.4% ...
Colgate-Palmolive surpassed earnings expectations in Q1 2025, despite experiencing a decline in overall sales.
JP Morgan analyst Andrea Teixeira maintained an Overweight rating and slashed the price target from $99 to $95 on April 11, ...
Shares in consumer products group Colgate-Palmolive (CL) shone brightly in early trading today as it reported forecast beating first quarter ...
Investing.com - Colgate-Palmolive (NYSE: CL) has slashed its full-year guidance for organic sales, becoming the latest ...
Colgate-Palmolive (NYSE: CL) shares rose premarket after Q1 FY25 earnings beat expectations. Revenue hit $4.91B, topping estimates, with 1.4% organic sales growth and $0.91 EPS exceeding forecasts.
Makers of our food and home essentials, including Pepsi and Procter & Gamble, are cutting their financial forecasts for the year and predicting lower sales or profits than before.
EDT Colgate-Palmolive (CL) says has changed many sourcing strategies over past 5 yearsStay Ahead of the Market: Discover outperforming ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results